Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | Y006602 | — |
Medical assistant reported that a patient missed second dose of RECOMBIVAX today. The patient received the first dose on 1/11/2025. No additional AEs were reported, no further information provided. No PQC.; No additional AE; This spontaneous report was received from a medical assistant and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-Jan-2025, the patient received the first dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), lot #Y006602, expiration date: 05-Feb-2026, administered for prophylaxis (strength, dose and rout e of administration were not provided). It was reported that the patient missed second dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) today (Inappropriate schedule of vaccine administered). No additional adverse events (AEs) were reported, no further information provided (No adverse event). This is a non-valid case due to lack of patient's identifiers.